Luye Pharma AG
6Patents
6Active
6Granted
47Portfolio score
Filing activity: Feb 17, 2011 → Mar 14, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10660863B2 | Transdermal therapeutic system for administering an active substance | Human Necessities | 1 | Active |
| US10759076B2 | Device for the manufacture of pharmaceutical patches | Human Necessities | 1 | Active |
| US10076502B2 | Transdermal therapeutic system for administering rivastigmine or derivatives thereof | Human Necessities | 0 | Active |
| US10758495B2 | Lattice loss reduction | Performing Operations; Transporting | 0 | Active |
| US11013697B2 | Transdermal therapeutic system with an overtape comprising two adhesive layers | Chemistry; Metallurgy | 0 | Active |
| US9616212B2 | Implant cannula having an implant and a method for securing implants in an injection cannula | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.